JP2024503623A5 - - Google Patents
Info
- Publication number
- JP2024503623A5 JP2024503623A5 JP2023541041A JP2023541041A JP2024503623A5 JP 2024503623 A5 JP2024503623 A5 JP 2024503623A5 JP 2023541041 A JP2023541041 A JP 2023541041A JP 2023541041 A JP2023541041 A JP 2023541041A JP 2024503623 A5 JP2024503623 A5 JP 2024503623A5
- Authority
- JP
- Japan
- Prior art keywords
- lnp
- item
- lipid
- formula
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163134376P | 2021-01-06 | 2021-01-06 | |
| US63/134,376 | 2021-01-06 | ||
| US202163147959P | 2021-02-10 | 2021-02-10 | |
| US63/147,959 | 2021-02-10 | ||
| US202163181917P | 2021-04-29 | 2021-04-29 | |
| US202163181663P | 2021-04-29 | 2021-04-29 | |
| US202163181899P | 2021-04-29 | 2021-04-29 | |
| US63/181,899 | 2021-04-29 | ||
| US63/181,917 | 2021-04-29 | ||
| US63/181,663 | 2021-04-29 | ||
| PCT/US2022/011450 WO2022150485A1 (en) | 2021-01-06 | 2022-01-06 | Encapsulated rna polynucleotides and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503623A JP2024503623A (ja) | 2024-01-26 |
| JP2024503623A5 true JP2024503623A5 (cg-RX-API-DMAC7.html) | 2025-02-03 |
Family
ID=82357635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541041A Pending JP2024503623A (ja) | 2021-01-06 | 2022-01-06 | カプセル化rnaポリヌクレオチド及び使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240115636A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4274591A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024503623A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230143141A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022206676A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3204244A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022150485A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250049948A1 (en) * | 2021-11-16 | 2025-02-13 | Sail Biomedicines, Inc. | Novel ionizable lipids and lipid nanoparticles and methods of using the same |
| WO2023223183A1 (en) * | 2022-05-16 | 2023-11-23 | Crispr Therapeutics Ag | Picornaviral vectors for gene editing |
| WO2024031078A2 (en) * | 2022-08-05 | 2024-02-08 | Elevatebio Technologies, Inc. | Chimeric oncolytic viruses with tropism for poliovirus receptor |
| IL320573A (en) | 2022-11-04 | 2025-07-01 | Life Edit Therapeutics Inc | Developed adenine deaminases and RNA-guided nuclease fusion proteins with internal insertion sites and methods of use |
| EP4642914A1 (en) * | 2022-12-28 | 2025-11-05 | ST Pharm. Co., Ltd. | Compositions and methods for generating circular rna |
| CN120826390A (zh) | 2023-01-31 | 2025-10-21 | 安斯泰来制药株式会社 | 具有环状胺的氨甲酰基脂质或脲脂质、含有其的脂质纳米粒子和药物组合物 |
| TW202438672A (zh) * | 2023-01-31 | 2024-10-01 | 美商亞克圖羅斯醫療公司 | 四價流感疫苗之方法及組成物 |
| WO2024178397A2 (en) | 2023-02-24 | 2024-08-29 | Elevatebio Technologies, Inc. | Modified immune effector cells and methods of use |
| WO2024226832A1 (en) * | 2023-04-25 | 2024-10-31 | Orgenesis Inc. | Ribonucleases for treating viral infections |
| EP4750890A2 (en) | 2023-07-27 | 2026-06-03 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
| CN122422501A (zh) | 2023-10-18 | 2026-07-17 | 生命编辑治疗股份有限公司 | Rna引导的核酸酶及其活性片段和变体以及使用方法 |
| WO2025174908A1 (en) | 2024-02-12 | 2025-08-21 | Life Edit Therapeutics, Inc. | Novel rna-guided nucleases and proteins for polymerase editing |
| TW202617985A (zh) | 2024-06-25 | 2026-05-01 | 美商生命編輯治療學公司 | 新穎反轉錄酶及其用途 |
| WO2026006491A1 (en) * | 2024-06-25 | 2026-01-02 | Cornell University | Senecavirus a (sva) vaccine compositions and methods thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102166218A (zh) * | 2005-01-17 | 2011-08-31 | 溶瘤病毒有限公司 | 治疗肿瘤的方法和组合物 |
| DK3386484T3 (da) * | 2015-12-10 | 2022-07-04 | Modernatx Inc | Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler |
| RU2020106730A (ru) * | 2017-07-14 | 2021-08-16 | Онкорус, Инк. | Инкапсулированные полинуклеотиды и способы их применения |
| MX2020002348A (es) * | 2017-08-31 | 2020-10-08 | Modernatx Inc | Métodos de elaboración de nanopartículas lipídicas. |
| ES3001512T3 (en) * | 2018-04-29 | 2025-03-05 | Global Life Sciences Solutions Canada Ulc | Compositions for transfecting resistant cell types |
| CA3124524A1 (en) * | 2019-01-04 | 2020-07-09 | Oncorus, Inc. | Encapsulated rna polynucleotides and methods of use |
| KR102732019B1 (ko) * | 2019-04-15 | 2024-11-20 | 글로벌 라이프 사이언시즈 솔루션즈 캐나다 유엘씨 | T 세포 유전자 발현의 비바이러스 변형 |
-
2022
- 2022-01-06 CA CA3204244A patent/CA3204244A1/en active Pending
- 2022-01-06 JP JP2023541041A patent/JP2024503623A/ja active Pending
- 2022-01-06 US US18/260,375 patent/US20240115636A1/en active Pending
- 2022-01-06 EP EP22737107.7A patent/EP4274591A4/en not_active Withdrawn
- 2022-01-06 WO PCT/US2022/011450 patent/WO2022150485A1/en not_active Ceased
- 2022-01-06 AU AU2022206676A patent/AU2022206676A1/en active Pending
- 2022-01-06 KR KR1020237026655A patent/KR20230143141A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022516318A5 (cg-RX-API-DMAC7.html) | ||
| Wang et al. | mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications | |
| ES2256265T3 (es) | Vectores de parvovirus duplicados. | |
| KR102142180B1 (ko) | 세포에 핵산을 도입하기 위한 조성물 | |
| JP2025063030A5 (cg-RX-API-DMAC7.html) | ||
| JP2023528300A5 (cg-RX-API-DMAC7.html) | ||
| TW202425953A (zh) | 脂質奈米顆粒 (lnp) 綴合物的製備 | |
| Cai et al. | Synthetic circRNA therapeutics: innovations, strategies, and future horizons | |
| JP2024531486A (ja) | 環状rnaを調製するための構築物及び方法 | |
| JP2024503623A (ja) | カプセル化rnaポリヌクレオチド及び使用方法 | |
| JP2026012402A5 (cg-RX-API-DMAC7.html) | ||
| Son et al. | Development of mRNA vaccines/therapeutics and their delivery system | |
| Zwolsman et al. | Engineering lipid nanoparticles for mRNA immunotherapy | |
| CN101307328A (zh) | 一种ck19重组腺相关病毒载体及其构建方法与应用 | |
| JP2022507269A5 (cg-RX-API-DMAC7.html) | ||
| Kairuz et al. | Advancing mRNA technologies for therapies and vaccines: An African context | |
| CN110168090A (zh) | mRNA的功能化方法 | |
| JP2023528300A (ja) | 封入されたrnaレプリコンおよび使用方法 | |
| WO2022069577A1 (en) | Engineered extracellular vesicles displaying enhanced pharmacokinetics | |
| CA3143627A1 (en) | Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines | |
| WO2024131403A1 (zh) | 基于核酸适体的脾脏及其亚细胞的mRNA靶向递送系统 | |
| Qu et al. | Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons | |
| Yang et al. | Advancing cancer treatment: in vivo delivery of therapeutic small noncoding RNAs | |
| Wang et al. | Targeted gene delivery systems for T-cell engineering | |
| CN116726198B (zh) | 一种抗肿瘤药物及其在脑胶质瘤治疗中的应用 |